Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03851302 · ClinicalTrials.gov registry record · NA

Effects of Remote Ischemic Conditioning on Hand Use in Individuals With SCI and ALS

A NA study, sponsored by Bronx VA Medical Center.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT03851302 is a NA study that has completed, run by Bronx VA Medical Center. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03851302, a NA study, has completed, sponsored by Bronx VA Medical Center.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Rehabilitation interventions such as physical training and neural stimulation after spinal cord injury (SCI) have been shown to increase neural plasticity. However, both physical training and neural stimulation require a large number of repetitions, and the retention of the intervention effects may be fleeting. In this proposal the investigators will test Remote ischemic conditioning (RIC), which has been shown to promote neural plasticity and has practical and theoretical advantages. RIC consists of transiently restricting blood flow to any 'remote' limb using a blood pressure cuff. This induces several of the body's systemic defensive reactions. RIC has been shown to improve motor learning. The investigators propose that RIC alters motor pathway excitability through a combination of systemic increases in plasticity-promoting factors and inhibition of inflammatory factors. The investigators have designed a clinical trial to test this hypothesis in 8 persons with SCI and 8 able-bodied controls. All participants will receive active/sham RIC plus a hand exercise. The investigators will measure effects on blood pressure, motor neuron excitability, and systemic inflammatory markers before and after RIC as well as after hand exercise. Starting July 2021, we will also enroll 5 individuals with Amyotrophic lateral sclerosis (ALS) in this study.

Interventions

  • OTHER Active Remote Ischemic Conditioning
  • OTHER Sham Remote Ischemic Conditioning
  • OTHER Isometric hand exercise

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-10-28
Est. Completion 2022-10-31
Phase NA

Sponsor

Bronx VA Medical Center

13 total trials

What the Registry Record Tells You About NCT03851302

The ClinicalTrials.gov registry entry for NCT03851302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bronx VA Medical Center, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Active Remote Ischemic Conditioning is the first listed.

NCT03851302 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03851302 about?

NCT03851302 is a clinical study titled "Effects of Remote Ischemic Conditioning on Hand Use in Individuals With SCI and ALS". Rehabilitation interventions such as physical training and neural stimulation after spinal cord injury (SCI) have been shown to increase neural plasticity. However, both physical training and neural stimulation require a large number of repetitions, and the retention of the intervention effects may ...

What is the current status of trial NCT03851302?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-10-28. Estimated completion is 2022-10-31.

What interventions are being tested in trial NCT03851302?

The interventions under investigation include: Active Remote Ischemic Conditioning (OTHER), Sham Remote Ischemic Conditioning (OTHER), Isometric hand exercise (OTHER).

Who is sponsoring clinical trial NCT03851302?

This trial is sponsored by Bronx VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.